Global Retirement Partners LLC Buys Shares of 17,517 CVS Health Corporation $CVS

Global Retirement Partners LLC purchased a new position in shares of CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 17,517 shares of the pharmacy operator’s stock, valued at approximately $1,208,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. Avion Wealth lifted its holdings in shares of CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Asset Planning Inc. acquired a new position in shares of CVS Health during the 2nd quarter worth approximately $30,000. Bell Investment Advisors Inc lifted its stake in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares in the last quarter. Roxbury Financial LLC grew its holdings in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 202 shares during the last quarter. Finally, ORG Partners LLC increased its position in CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Price Performance

CVS Health stock opened at $79.88 on Thursday. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83. The firm has a 50 day moving average price of $78.43 and a 200 day moving average price of $70.52. The company has a market cap of $101.40 billion, a price-to-earnings ratio of 210.22, a PEG ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter last year, the business earned $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is 700.00%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Wells Fargo & Company decreased their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research note on Thursday, November 13th. Evercore ISI upped their target price on shares of CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. UBS Group lifted their price target on shares of CVS Health from $79.00 to $96.00 and gave the stock a “buy” rating in a report on Friday, October 24th. Cowen reissued a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Finally, Royal Bank Of Canada lifted their target price on shares of CVS Health from $81.00 to $93.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Two analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $89.41.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.